Page last updated: 2024-08-21

norfenfluramine and Hypertension, Pulmonary

norfenfluramine has been researched along with Hypertension, Pulmonary in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dempsie, Y; Loughlin, L; MacLean, MR; MacRitchie, NA; Mair, KM; Morecroft, I; Nilsen, M; White, K; Wright, AF	1
Andréjak, M; Maréchaux, S; Peltier, M; Szymanski, C; Tribouilloy, C	1
Chalmers, SR; Douglas, JG; Frazer, I; Gough, J; Haslett, C; Munro, JF; Preston, PG	1

Reviews

1 review(s) available for norfenfluramine and Hypertension, Pulmonary

Article	Year
Adverse effects of benfluorex on heart valves and pulmonary circulation. Pharmacoepidemiology and drug safety, 2014, Volume: 23, Issue:7 Topics: Echocardiography; Fenfluramine; Heart Valve Diseases; Heart Valves; Humans; Hypertension, Pulmonary; Hypolipidemic Agents; Norfenfluramine; Pulmonary Circulation; Randomized Controlled Trials as Topic; Receptor, Serotonin, 5-HT2B	2014

Trials

1 trial(s) available for norfenfluramine and Hypertension, Pulmonary

Article	Year
Long-term efficacy of fenfluramine in treatment of obesity. Lancet (London, England), 1983, Feb-19, Volume: 1, Issue:8321 Topics: Body Weight; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Fenfluramine; Humans; Hypertension, Pulmonary; Norfenfluramine; Obesity; Recurrence; Tablets; Time Factors	1983

Other Studies

1 other study(ies) available for norfenfluramine and Hypertension, Pulmonary

Article	Year
Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension. Cardiovascular research, 2013, Jul-01, Volume: 99, Issue:1 Topics: Animals; Arterial Pressure; Aryl Hydrocarbon Hydroxylases; Cell Proliferation; Cells, Cultured; Cytochrome P-450 CYP1B1; Dexfenfluramine; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Familial Primary Pulmonary Hypertension; Female; Hypertension, Pulmonary; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Norfenfluramine; Ovariectomy; Pulmonary Artery; Serotonin; Sex Factors; Tryptophan Hydroxylase; Ventricular Function, Right; Ventricular Pressure	2013

Article

Year

Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension.

Cardiovascular research, 2013, Jul-01, Volume: 99, Issue:1

Topics: Animals; Arterial Pressure; Aryl Hydrocarbon Hydroxylases; Cell Proliferation; Cells, Cultured; Cytochrome P-450 CYP1B1; Dexfenfluramine; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Familial Primary Pulmonary Hypertension; Female; Hypertension, Pulmonary; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Norfenfluramine; Ovariectomy; Pulmonary Artery; Serotonin; Sex Factors; Tryptophan Hydroxylase; Ventricular Function, Right; Ventricular Pressure

2013